Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate if the delayed administration of everolimus could reduce the everolimus associated "anti-proliferative complications" (e.g. wound healing disorder) while maintaining efficacy, when compared to the immediate administration of everolimus in de novo renal transplant patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Recipients of cadaveric kidney transplants
Patients at risk of DGF defined as one or more of the following:
Exclusion criteria
Other protocol-defined exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
139 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal